Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 45,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
Responsible for all aspects of regulatory affairs, including strategic and operational leadership relative to the direction, planning, execution and conduct of Nevro’s regulatory objectives. Ensure compliance with applicable regulations and SOPs, and in accordance with expected timelines and budgets. Provides functional leadership, management and development to the others within the Regulatory Department. This is a hands-on position.